Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 47.77
-0.30 (-0.62%)
Sep 30, 2025, 3:30 PM IST
Morepen Laboratories Employees
Morepen Laboratories had 1,814 employees as of March 31, 2025. The number of employees decreased by 338 or -15.71% compared to the previous year.
Employees
1,814
Change (1Y)
-338
Growth (1Y)
-15.71%
Revenue / Employee
9.93M INR
Profits / Employee
510.48K INR
Market Cap
26.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,814 | -338 | -15.71% |
| Mar 31, 2024 | 2,152 | 503 | 30.50% |
| Mar 31, 2023 | 1,649 | 42 | 2.61% |
| Mar 31, 2022 | 1,607 | 97 | 6.42% |
| Mar 31, 2021 | 1,510 | -45 | -2.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
Morepen Laboratories News
- 21 days ago - Morepen Laboratories shares rally over 4% after company forms 50:50 Joint Venture with UAE’s Bimedical FZE - Business Upturn
- 21 days ago - Morepen Laboratories subsidiary to form 50:50 JV with UAE’s Bimedical FZE for medical devices business - Business Upturn
- 7 weeks ago - Morepen Laboratories shares drop 4% as Q1 net profit drops 68.5% YoY to Rs 11.4 crore - Business Upturn
- 7 weeks ago - Morepen Laboratories Q1 Results: Net profit plunges 68% YoY to Rs 11.4 crore, revenue down 6.6% YoY - Business Upturn
- 4 months ago - Morepen Laboratories secures Rs 50 crore loan facility from Qatar National Bank - Business Upturn
- 5 months ago - Morepen Laboratories share price drops 3% as Q4 Ebitda falls 12.6% to Rs 42.3 crore - Business Upturn
- 5 months ago - Morepen Laboratories receives SEC clearance for Resmetirom bioequivalence studies - Business Upturn
- 5 months ago - Morepen Labs shares rally 7% today on this major update – Know More - Business Upturn